Fluorescence quenching of graphene oxide combined with the site-specific cleavage of restriction endonuclease for deoxyribonucleic acid demethylase activity assay

• An approach for sensitive and selective DNA demethylase activity assay is reported.
• This assay is based on the fluorescence quenching of GO and site-specific cleavage of endonuclease.
• It can determine as low as 0.05 ng mL−1 of MBD2 with a linear range of 0.2–300 ng mL−1.
• It has an ability to recognize MBD2 from other possibly coexisting proteins and cancer cell extracts.
• It can avoid false signals, requiring no bisulfite conversion, PCR amplification, radioisotope-labeling.

We report on the development of a sensitive and selective deoxyribonucleic acid (DNA) demethylase (using MBD2 as an example) activity assay by coupling the fluorescence quenching of graphene oxide (GO) with the site-specific cleavage of HpaII endonuclease to improve the selectivity. This approach was developed by designing a single-stranded probe (P1) that carries a binding region to facilitate the interaction with GO, which induces fluorescence quenching of the labeled fluorophore (FAM, 6-carboxyfluorescein), and a sensing region, which contains a hemi-methylated site of 5′-CmCGG-3′, to specifically recognize the target (T1, a 32-mer DNA from the promoter region of p53 gene) and hybridize with it to form a P1/T1 duplex. After demethylation with MBD2, the duplex can be specifically cleaved using HpaII, which releases the labeled FAM from the GO surface and results in the recovery of fluorescence. However, this cleavage is blocked by the hemi-methylation of this site. Thus, the magnitude of the recovered fluorescence signal is related to the MBD2 activity, which establishes the basis of the DNA demethylase activity assay. This assay can determine as low as ∼(0.05 ± 0.01) ng mL−1 (at a signal/noise of 3) of MBD2 with a linear range of 0.2–300 ng mL−1 and recognize MBD2 from other possibly coexisting proteins and cancer cell extracts. The advantage of this assay is its ability to avoid false signals and no requirement of bisulfite conversion, PCR amplification, radioisotope labeling, or separation.

Figure optionsDownload as PowerPoint slide